KIN

Kindred Biosciences (KIN)

Kindred Biosciences Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:KIN

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2022/02/15	07 : 35	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:KIN	Kindred Biosciences Inc
2022/02/15	01 : 14	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:KIN	Kindred Biosciences Inc
2021/09/02	19 : 05	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:KIN	Kindred Biosciences Inc
2021/08/31	07 : 08	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KIN	Kindred Biosciences Inc
2021/08/31	06 : 44	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KIN	Kindred Biosciences Inc
2021/08/31	06 : 18	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KIN	Kindred Biosciences Inc
2021/08/31	05 : 47	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KIN	Kindred Biosciences Inc
2021/08/31	03 : 56	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KIN	Kindred Biosciences Inc
2021/08/31	03 : 35	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KIN	Kindred Biosciences Inc
2021/08/30	22 : 22	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:KIN	Kindred Biosciences Inc
2021/08/30	22 : 20	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:KIN	Kindred Biosciences Inc
2021/08/30	22 : 17	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:KIN	Kindred Biosciences Inc
2021/08/30	22 : 15	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:KIN	Kindred Biosciences Inc
2021/08/30	22 : 09	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:KIN	Kindred Biosciences Inc
2021/08/30	22 : 06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:KIN	Kindred Biosciences Inc
2021/08/30	22 : 05	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:KIN	Kindred Biosciences Inc
2021/08/28	06 : 37	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:KIN	Kindred Biosciences Inc
2021/08/10	19 : 01	Edgar (US Regulatory)	Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)	NASDAQ:KIN	Kindred Biosciences Inc
2021/08/10	05 : 27	Edgar (US Regulatory)	Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)	NASDAQ:KIN	Kindred Biosciences Inc
2021/08/06	05 : 26	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:KIN	Kindred Biosciences Inc
2021/08/06	05 : 15	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:KIN	Kindred Biosciences Inc
2021/08/02	22 : 07	Edgar (US Regulatory)	Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)	NASDAQ:KIN	Kindred Biosciences Inc
2021/08/02	22 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:KIN	Kindred Biosciences Inc
2021/07/21	22 : 11	Edgar (US Regulatory)	Proxy Statement - Merger or Acquisition (definitive) (defm14a)	NASDAQ:KIN	Kindred Biosciences Inc
2021/07/12	21 : 30	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:KIN	Kindred Biosciences Inc
2021/07/10	06 : 31	Edgar (US Regulatory)	Proxy Statement - Merger or Acquisition (preliminary) (prem14a)	NASDAQ:KIN	Kindred Biosciences Inc
2021/07/08	01 : 03	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KIN	Kindred Biosciences Inc
2021/07/01	22 : 05	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:KIN	Kindred Biosciences Inc
2021/06/30	21 : 21	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:KIN	Kindred Biosciences Inc
2021/06/26	05 : 33	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:KIN	Kindred Biosciences Inc